U.S. federal trademark · Serial No. 97489282
RNA editing gene therapeutics being pharmaceutical preparations for editing RNA for the treatment of inherited genetic diseases; RNA editing gene therapeutics being pharmaceutical preparations for editing RNA to treat inherited genetic diseases; RNA editing gene therapeutics being pharmaceutical preparations for editing RNA to treat inherited human genetic diseases; RNA-based gene therapies being pharmaceutical preparations for treatment of muscular dystrophies; RNA-based gene therapies being pharmaceutical preparations for the treatment of inherited neurological diseases; RNA-based gene therapies being pharmaceutical preparations for treatment of inherited retinal dystrophies; RNA-based gene therapies being pharmaceutical preparations for treatment of cancer; RNA-based gene therapies being pharmaceutical preparations for treatment of genetic liver diseases; RNA-based gene therapies being pharmaceutical preparations for treatment of inherited blood disorders
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.